BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26503140)

  • 1. Imaging Tumor Metastases with Molecular Probes.
    Qiao R; Zhu R; Gao M
    Curr Pharm Des; 2015; 21(42):6260-4. PubMed ID: 26503140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPECT and PET serve as molecular imaging techniques and in vivo biomarkers for brain metastases.
    Palumbo B; Buresta T; Nuvoli S; Spanu A; Schillaci O; Fravolini ML; Palumbo I
    Int J Mol Sci; 2014 Jun; 15(6):9878-93. PubMed ID: 24897023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging of tumor invasion and metastases: the role of MRI.
    McCann TE; Kosaka N; Turkbey B; Mitsunaga M; Choyke PL; Kobayashi H
    NMR Biomed; 2011 Jul; 24(6):561-8. PubMed ID: 21793070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Options for visualizing metastatic disease in the living body.
    Helms MW; Brandt BH; Contag CH
    Contrib Microbiol; 2006; 13():209-231. PubMed ID: 16627968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe.
    Misri R; Meier D; Yung AC; Kozlowski P; Häfeli UO
    Nanomedicine; 2012 Aug; 8(6):1007-16. PubMed ID: 22100757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET-MR and SPECT-MR multimodality probes: Development and challenges.
    Yang CT; Ghosh KK; Padmanabhan P; Langer O; Liu J; Eng DNC; Halldin C; Gulyás B
    Theranostics; 2018; 8(22):6210-6232. PubMed ID: 30613293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of Molecular Probes for Live Imaging of Cancer and Infectious Diseases].
    Fuchigami T
    Yakugaku Zasshi; 2019; 139(12):1531-1538. PubMed ID: 31787640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular probes for the in vivo imaging of cancer.
    Alford R; Ogawa M; Choyke PL; Kobayashi H
    Mol Biosyst; 2009 Nov; 5(11):1279-91. PubMed ID: 19823742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Imaging of Pancreatic Cancer with Antibodies.
    England CG; Hernandez R; Eddine SB; Cai W
    Mol Pharm; 2016 Jan; 13(1):8-24. PubMed ID: 26620581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular tracers for the PET and SPECT imaging of disease.
    Pimlott SL; Sutherland A
    Chem Soc Rev; 2011 Jan; 40(1):149-62. PubMed ID: 20818455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).
    Rangasamy L; Geronimo BD; Ortín I; Coderch C; Zapico JM; Ramos A; de Pascual-Teresa B
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31426440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Imaging of Abdominal Aortic Aneurysms.
    Brangsch J; Reimann C; Collettini F; Buchert R; Botnar RM; Makowski MR
    Trends Mol Med; 2017 Feb; 23(2):150-164. PubMed ID: 28110838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of high resolution whole-body MRI using parallel imaging and PET-CT. First experiences with a 32-channel MRI system].
    Schmidt GP; Baur-Melnyk A; Tiling R; Hahn K; Reiser MF; Schoenberg SO
    Radiologe; 2004 Sep; 44(9):889-98. PubMed ID: 15349732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and Molecular Imaging with SPECT and PET in Brain Tumors.
    Sadaghiani MS; Sheikhbahaei S; Rowe SP; Pomper MG; Solnes LB
    Radiol Clin North Am; 2021 May; 59(3):363-375. PubMed ID: 33926683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannot Target What Cannot Be Seen: Molecular Imaging of Cancer Stem Cells.
    Marcu LG; Moghaddasi L; Bezak E
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted nuclear imaging of breast cancer: status of radiotracer development and clinical applications.
    Kong FL; Kim EE; Yang DJ
    Cancer Biother Radiopharm; 2012 Mar; 27(2):105-12. PubMed ID: 21877909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging of breast cancer.
    Oude Munnink TH; Nagengast WB; Brouwers AH; Schröder CP; Hospers GA; Lub-de Hooge MN; van der Wall E; van Diest PJ; de Vries EG
    Breast; 2009 Oct; 18 Suppl 3():S66-73. PubMed ID: 19914546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New frontiers in the design and synthesis of imaging probes for PET oncology: current challenges and future directions.
    Smith G; Carroll L; Aboagye EO
    Mol Imaging Biol; 2012 Dec; 14(6):653-66. PubMed ID: 22948535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides for in vivo target-specific cancer imaging.
    Ferro-Flores G; Ramírez Fde M; Meléndez-Alafort L; Santos-Cuevas CL
    Mini Rev Med Chem; 2010 Jan; 10(1):87-97. PubMed ID: 20380643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments of magnetic resonance imaging and spectroscopy in the field of molecular imaging.
    Aime S; Bisi G
    Q J Nucl Med Mol Imaging; 2009 Dec; 53(6):563-4. PubMed ID: 20016449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.